Dr. Agarwal’s Health Care IPO Details, Dates, and Key Information 2025
Dr. Agarwal’s Health Care IPO is set to open for subscription on January 29, 2025, and close on January 31, 2025. This is a Book Built Issue IPO with a total issue size of ₹3,027.26 crores. The IPO includes a fresh issue of ₹300 crores and an offer for sale of 2,727.26 crore equity shares with a face value of ₹1 each. The price band is ₹382 to ₹402 per share, with the IPO listing scheduled on February 5, 2025, on BSE and NSE.
Key IPO Highlights
IPO Details:
- Open Date: January 29, 2025
- Close Date: January 31, 2025
- Issue Type: Book Built Issue
- Face Value: ₹1 per share
- Price Band: ₹382 to ₹402 per share
- Issue Size: ₹3,027.26 crores
- Fresh Issue: ₹300 crores
- Offer for Sale: Approx. 6,78,42,284 shares
- Retail Quota: 35%
- QIB Quota: 50%
- HNI/NII Quota: 15%
- Listing Platforms: BSE and NSE
Important Dates:
- IPO Allotment Finalization: February 3, 2025
- Refunds Processed: February 4, 2025
- Credit to Demat Accounts: February 4, 2025
- Listing Date: February 5, 2025
Market Lot and Application Details
Dr. Agarwal’s Health Care IPO has the following market lot and application details:
| Investor Type | Lot Size | Shares | Amount (₹) |
|---|---|---|---|
| Retail Minimum | 1 | 35 | ₹14,070 |
| Retail Maximum | 13 | 490 | ₹1,96,980 |
| S-HNI Minimum | 14 | 525 | ₹2,11,050 |
| B-HNI Minimum | 68 | 2,520 | ₹10,13,040 |
The minimum application for retail investors is 35 shares at ₹14,070, while retail investors can apply for a maximum of 490 shares at ₹1,96,980.
Financial Overview
Dr. Agarwal’s Health Care reported a significant growth trajectory in recent years:
| Year | Revenue (₹ Cr.) | Expenses (₹ Cr.) | Profit After Tax (₹ Cr.) | Assets (₹ Cr.) |
|---|---|---|---|---|
| 2022 | 713.78 | 657.02 | 43.16 | 1,026.13 |
| 2023 | 1,031.49 | 947.90 | 103.23 | 1,825.17 |
| 2024 | 1,376.45 | 1,235.88 | 95.05 | 2,752.82 |
| Sep 2024 | 837.94 | 777.59 | 39.56 | 3,393.41 |
2024 Financial Summary:
- Revenue increased by 33% from 2023 to ₹1,376.45 crores.
- Profit dipped slightly, from ₹103.23 crores in 2023 to ₹95.05 crores in 2024.
- Total assets grew significantly to ₹2,752.82 crores in 2024.
Valuation Metrics
The IPO’s valuation metrics highlight its competitive position:
| Metric | Value |
|---|---|
| ROE (Return on Equity) | 3.14% |
| ROCE (Return on Capital Employed) | 5.95% |
| EBITDA Margin | 26.91% |
| PAT Margin | 4.70% |
| Debt-to-Equity Ratio | 0.70 |
| EPS (Basic) | ₹3.14 |
| NAV | ₹50.53 |
Peer Comparison
Dr. Agarwal’s Health Care competes with other established players in the healthcare sector. Here’s a comparison of key metrics:
| Company | EPS (₹) | PE Ratio | RoNW (%) | NAV (₹) | Income (₹ Cr.) |
|---|---|---|---|---|---|
| Apollo Hospitals | 62.50 | 107.11 | 12.97% | 481.93 | 19,059.20 |
| Max Healthcare Institute | 10.89 | 95.88 | 12.58% | 86.54 | 6,849.00 |
| Fortis Healthcare | 7.93 | 82.11 | 7.82% | 101.48 | 6,892.92 |
| Narayana Hrudayalaya | 38.86 | 33.14 | 27.37% | 141.98 | 5,018.25 |
Objects of the IPO
The IPO proceeds will be utilized for the following:
- Repayment or prepayment of borrowings.
- General corporate purposes.
- Unidentified inorganic acquisitions.
Promoters
The promoters include Dr. Amar Agarwal, Dr. Athiya Agarwal, and other members of the Agarwal family.
Lead Managers
The IPO is managed by reputed lead managers, including:
- Kotak Mahindra Capital Company
- Morgan Stanley India Company
- Jefferies India Private Limited
Registrar
The IPO registrar is KFin Technologies Limited.
Contact Details:
- Phone: 040-67162222
- Email: ahcl.ipo@kfintech.com
- Website: KFintech
FAQs
1. When does Dr. Agarwal’s Health Care IPO open and close?
The IPO opens on January 29, 2025, and closes on January 31, 2025.
2. What is the IPO price band?
The price band is ₹382 to ₹402 per share.
3. What is the minimum application size?
The minimum application is 35 shares, amounting to ₹14,070.
4. When will the shares be listed?
The shares will be listed on February 5, 2025, on BSE and NSE.
5. What is the IPO’s objective?
The funds will be used for debt repayment, corporate purposes, and inorganic acquisitions.
Conclusion
Dr. Agarwal’s Health Care IPO presents an opportunity for investors interested in the growing healthcare sector. With a robust financial history, clear growth strategies, and a competitive price band, it offers potential for long-term gains. Investors should assess their risk appetite before applying.